·
10 Min Read

New long COVID clinical trials, FDA approves postpartum depression pill & RSV shot for babies [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the latest on long COVID and more.

series
Infectious Diseases
AMA Update Podcast
·
10 Min Read

New long COVID clinical trials, FDA approves postpartum depression pill & RSV shot for babies

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about the latest on long COVID and more.

series
Infectious Diseases
AMA Update
Map of USA with string wrapped around it
·
6 Min Read

After Dobbs, M4s face stark reality when applying for residency

Ob-gyn residency-applicant volume fell in states with abortion bans during the 2022–2023 cycle. Learn more with the AMA.

series
Prep for Residency
The Road to Residency
·
4 Min Read

July 28, 2023: National Advocacy Update

FDA approves first over-the-counter oral contraceptive and more in the latest National Advocacy Update.

Advocacy Update
·
10 Min Read

Aspartame, OTC birth control pill, MMR & COVID vaccines with Andrea Garcia, JD, MPH

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about over-the-counter birth control pill, MMR and COVID-19 vaccines, and more.

series
Population Health
AMA Update
·
10 Min Read

Aspartame, OTC birth control pill, MMR & COVID vaccines with Andrea Garcia, JD, MPH [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about over-the-counter birth control pill, MMR and COVID-19 vaccines, and more.

series
Population Health
AMA Update Podcast
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of July 10, 2023

In the news: OTC contraceptive approved, prior authorization a tool “to delay and deny care,” deepening mental health crisis in the U.S. and more.

Publications & Newsletters
·
2 Min Read

AMA applauds FDA approval of OTC birth control

The FDA’s approval for over-the-counter birth control is a monumental step to provide broader access to safe reproductive health care for millions of patients.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of July 3, 2023

In the news: New Alzheimer’s drug gets FDA approval, maternal mortality rates double, PFAS in drinking water and more.

Publications & Newsletters